GLAXOSMITHKLINE PHARMA A/S
CVR 27394019 · Public limited company (A/S) · Active · Low risk
GLAXOSMITHKLINE PHARMA A/S is a Public limited company (A/S), founded on , based in Vallensbæk Strand. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 39.0m and a net result of DKK 13.1m. CEO: Diederik Maarten Eijsvogel.
Bankruptcy risk for GLAXOSMITHKLINE PHARMA A/S
0.0 × the average (1.41%) · higher risk than 0% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 27394019
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (57 years)
- Address
- Delta Park 37
2665 Vallensbæk Strand - Municipality
- Vallensbæk
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 10.0m
- Employees
- 80 (2018)
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 31 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 32.3% |
| Current ratio | 146% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 8 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 16 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | DKK 580.8m | DKK 548.5m | DKK 474.5m |
| Gross profit | DKK 118.8m | DKK 134.5m | DKK 119.8m |
| Net profit | DKK 13.1m | DKK 12.2m | DKK 12.0m |
| Equity | DKK 39.0m | DKK 38.1m | DKK 37.9m |
| Total assets | DKK 120.7m | DKK 99.1m | DKK 117.3m |
| Short-term debt | DKK 81.7m | DKK 61.0m | – |
| Tax owed | DKK 1.8m | – | – |
| Avg. employees | 71,000 | 73 | – |
Latest annual report: Reporting class C, medium-size enterprise · auditor's statement: Auditor's report on audited financial statements · Deloitte.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 176 | ||
| 1 Jan 2024 – 31 Dec 2024 | 177 | ||
| 1 Jan 2023 – 31 Dec 2023 | 178 | ||
| 1 Jan 2022 – 31 Dec 2022 | 172 | ||
| 1 Jan 2021 – 31 Dec 2021 | 179 | ||
| 1 Jan 2020 – 31 Dec 2020 | 151 | ||
| 1 Jan 2019 – 31 Dec 2019 | 150 | ||
| 1 Jan 2018 – 31 Dec 2018 | 155 | ||
| 1 Jan 2017 – 31 Dec 2017 | 168 | ||
| 1 Jan 2016 – 31 Dec 2016 | 171 | ||
| 1 Jan 2015 – 31 Dec 2015 | 162 | ||
| 1 Jan 2014 – 31 Dec 2014 | 155 | ||
| 1 Jan 2013 – 31 Dec 2013 | 149 | ||
| 1 Jan 2012 – 31 Dec 2012 | 133 | ||
| 1 Jan 2011 – 31 Dec 2011 | 127 | ||
| 1 Jan 2010 – 31 Dec 2010 | 144 | ||
| 1 Jan 2009 – 31 Dec 2009 | 150 | ||
| 1 Jan 2008 – 31 Dec 2008 | 126 | ||
| 1 Jan 2007 – 31 Dec 2007 | 114 | ||
| 1 Jan 2006 – 31 Dec 2006 | 106 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Diederik Maarten Eijsvogel | Current | |
| CEO | Carl Christian Juhlsgaard Jepsen | ||
| CEO | Frederik Jan van Snippenberg | ||
| CEO | Frederik Jan van Snippenberg | ||
| CEO | Michael John Crow | ||
| CEO | Dominika M Wiktor-Brown | ||
| Board | Helle Ann Hellberg | Current | |
| Board | Luciano Alves de Andrade | Current | |
| Board | Diederik Maarten Eijsvogel | Current | |
| Board | Alastair William Jones | Current | |
| Board | Helge Hassel | ||
| Board | Carl Christian Juhlsgaard Jepsen | ||
| Board | Angus Robertson | ||
| Board | Simon Cresey Davidson | ||
| Board | Siero Keimpe Roosjen | ||
| Board | Frederik Jan van Snippenberg | ||
| Board | Frederik Jan van Snippenberg | ||
| Board | Michael John Crow | ||
| Board | Douglas Malcolm Hurt | ||
| Board | Hans Hedegaard | ||
| Board | Geradus Wilhelmus Maria van Odijk | ||
| Board | Simon Anthony Jose | ||
| Board | David Simon Redfern | ||
| Board | Julie Maree Edwards | ||
| Board | Frederik Jan van Snippenberg | ||
| Board | Michael Francis Connell | ||
| Board | Ole Jensen-Dahm | ||
| Board | Georgios Katzourakis | ||
| Board | Judith Lynne Stewart | ||
| Board | Birgit Yvonne Reimann | ||
| Board | Daniël Gijbels | ||
| Board | Josephine Yang Comiskey | ||
| Board | Josephine Yang Comiskey | ||
| Board | Saskia Fontein | ||
| Board | Neale Andrew Belson | ||
| Board | David Mattheus Fredericus Rademakers | ||
| Board | Anne Margaret Belcher | ||
| Board | Tetiana Luczkiw | ||
| Board | Patrick Gerard Connor | ||
| Board | Hemal Depan Malde | ||
| Board | Dominika M Wiktor-Brown | ||
| Board | Joshua Rhys Williams | ||
| Owner (100%) | Setfirst Limited | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB |
The CEOs' other companies
Carl Christian Juhlsgaard Jepsen – 3 other companies
- QATOR ApS Active
- TJELLESEN MAX JENNE A/S Active
- WELLCOME DANMARK A/S Fusioneret
Address history (2 moves)
| Delta Park 37, 2665 Vallensbæk Strand | |
| Delta Park 37, 2665 Vallensbæk Strand | |
| Nykær 68, 2605 Brøndby |
Former names
| GLAXOSMITHKLINE PHARMA A/S | – now |
| GLAXO DANMARK A/S | – |
| GLAXO WELLCOME A/S | – |
| GLAXO LÆGEMIDLER A/S | – |
Employees per year
Other companies at the same address
- NORSTAR A/S Bankrupt
- TOP-TOY A/S Bankrupt
- TOP-TOY Holding II A/S Bankrupt
- TOP-TOY Holding III A/S Bankrupt
- DR. OETKER DANMARK A/S Active
- EPLAN SOFTWARE & SERVICE A/S Opløst
- FERROSAN ApS Active
- FERROSAN INTERNATIONAL ApS Fusioneret
- Groupe SEB Denmark A/S Active
- Haleon Denmark ApS Active
- JTI DENMARK A/S Active
- OBH NORDICA IP A/S Fusioneret
- RICOH CAPITAL DANMARK A/S Active
- RICOH DANMARK A/S Active
- RITTAL A/S Active
- TOP-TOY Company ApS Opløst
Similar companies in Vallensbæk
- Haleon Denmark ApS Vallensbæk Strand
- 2San ApS Vallensbæk
- TAKEDA PHARMA A/S Vallensbæk Strand
- PREPPERZ ApS Vallensbæk Strand
- INTERMEDITECH ApS Vallensbæk Strand
Questions and answers about GLAXOSMITHKLINE PHARMA A/S
Has GLAXOSMITHKLINE PHARMA A/S gone bankrupt?
No, GLAXOSMITHKLINE PHARMA A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of GLAXOSMITHKLINE PHARMA A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of GLAXOSMITHKLINE PHARMA A/S?
Diederik Maarten Eijsvogel is the CEO of GLAXOSMITHKLINE PHARMA A/S.
Who is the auditor of GLAXOSMITHKLINE PHARMA A/S?
GLAXOSMITHKLINE PHARMA A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was GLAXOSMITHKLINE PHARMA A/S founded?
GLAXOSMITHKLINE PHARMA A/S was founded on 11 December 1968.
What is the equity of GLAXOSMITHKLINE PHARMA A/S?
Equity was DKK 39.0m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.